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ABSTRACT
Aging has been associated with peripheral insulin resistance in
both humans and rats. However, the specific tissues that become
insensitive to insulin before glucose homeostasis is altered remain to
be elucidated. In the present work we studied the glucose metabolic
index of a number of tissues known to be insulin sensitive in 3- and
24-month-old Wistar rats by measuring 2-deoxy-D-[1-3H]glucose up-
take both under euglycemic-hyperinsulinemic conditions and in the
basal state. Analysis of the glucose infusion rate to maintain normo-
glycemia during the clamp confirmed that the old rats show overall
insulin resistance at both saturating and subsaturating insulin con-
centrations. The maximal response of glucose uptake to insulin as
well as insulin sensitivity in red andwhite quadriceps were unaltered
in old rats. In contrast, glucose uptake by soleus and diaphragm was
poorly stimulated in old animals, and a marked decrease in insulin
sensitivity was observed in both tissues. In heart, only the sensitivity
to the hormone, not the maximal response, was impaired in old rats.
In white adipose tissue, no significant stimulation was detected. We
conclude that during aging in Wistar rats and before fasting plasma
insulin and glucose levels become altered, specific tissues develop
insulin resistance, whereas other remain insulin sensitive. We pos-
tulate that fat tissue plays a qualitative important role in eliciting the
insulin resistance in old animals. Due to themetabolic characteristics
of the agedWistar rat, the changes reportedmight reflect what occurs
in nonobese elderly humans, nongenetically committed to develop
type 2 diabetes. (Endocrinology 138: 49–54, 1997)
ASSOCIATION of impaired glucose tolerance with ad-vancing age in humans has been well documented by
many investigators using either an oral or iv glucose toler-
ance test (1). The use of the euglycemic-hyperinsulinemic
clamp technique allowed demonstration that the glucose
intolerance observed with aging is due to peripheral insulin
resistance (2–4). In rats, increases in insulin resistance in vivo
with aging have also been reported (5–8), and in a study in
which the euglycemic-hyperinsulinemic clamp was used, it
was concluded that decreased peripheral insulin sensitivity
is the main cause of the insulin resistance during aging in
mature animals (7).
As skeletal muscle is the main tissue responsible for in-
sulin-induced glucose disposal, most studies have explored
possible cellular changes in muscle as a cause of the periph-
eral insulin resistance in the aged rat (5, 6, 9–13). However,
the specific contribution of the different tissues that behave
as targets of insulin action to the overall insulin resistance is
as yet unknown. In the present work we studied the utili-
zation of glucose by a number of tissues (brain, lung, white
adipose, and several muscles) under euglycemic-hyperinsu-
linemic clamp conditions in young adult (3 months) and old
(24 months) rats. The age of the animals was selected to
analyze the effect of aging in mature animals and not the
effects of growth or maturation (8, 12), as is the case in most
studies in aging research that compare juvenile (1–2 month)
and either adult (4–12 month) or old (.20 month) animals
(6, 11, 14, 15).
Another major concern in aging research in rodents is the
rat strain to be used. Thus, to analyze changes in insulin
sensitivity of primary character it is important that the aged
rat is able to preserve glucose homeostasis without increases
in the plasma insulin concentration. On the other hand, age-
associated changes in body composition, such as increased
adiposity and body weight, are known to result in insulin
resistance, a fact that precludes the use of rat strains with
age-associated obesity. The Fisher 344 rat shows a small
increase in body weight at 24 months of age and, therefore,
has been used in many studies (8, 10, 11, 13, 16). However,
in this strain, fat cell size increases sharply, and fasting
plasma insulin concentrations are slightly higher in aged
animals, a situation that does not allow the determination of
whether changes in insulin sensitivity are due to the aging
process or to hyperinsulinemia. This last problem is also
shared by the Sprague-Dawley strain, which, in turn, shows
an acute increment in bodyweight during aging (5, 6, 17). On
the contrary, the 24-month-old Wistar rat shows fasting
plasma insulin concentrations identical to those of the adult
3-month-old rat and, despite an obvious increase in body
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weight and fat tissue mass, the size of adipose cells remains
constant (18), suggesting that the higher adipose tissue mass
is a consequence of adipocyte proliferation. Consequently,
studies in this report were conducted using the Wistar rat
strain, which we consider more appropriate to analyze ag-
ing-associated primary alterations in peripheral insulin sen-
sitivity. This strain has also been considered an adequate
model for aging studies by other researchers (9).
Materials and Methods
Animals
Three- and 24-month-old male Wistar rats fed ad libitum standard
laboratory chow and water were used throughout this study. Animals
were obtained from the colony maintained at the Center for Molecular
Biology (Madrid, Spain) where they were housed two per cage in cli-
mate-controlled quarters with a 12-h light cycle. Animal facilities fulfill
the requirements of the European laws on the protection of animals.
Euglycemic-insulin clamp
These studies were performed during the postabsorptive period, 15 h
after removal of food. Rats were anesthetized with pentobarbital (4
mg/100 g BW), and after tracheotomy (to avoid respiratory problems),
one carotid artery was catheterized for blood sampling. Once glycemia
returned to the level observed in blood withdrawn from the tail vein of
the awake animals (40 min), insulin (Actrapid, Novo, Copenhagen,
Denmark) was infused through a saphenous vein at a constant rate to
reach an insulin dose of 0.3 or 0.6U/hzkg, respectively. A solution of 30%
glucose was also infused through the other saphenous vein beginning
5min after the start of hormone infusion. The infusion rate was adjusted
to clamp blood glucose at the level present in awake animals (19). To
achieve this, blood samples were taken every 5 min from the carotid
artery, blood glucose was determined within 2 min using a Reflolux II
Glucose Analyzer (Boehringer Mannheim, Mannheim, Germany) (20),
and the pump dial was adjusted according to the changes in the blood
glucose level. Within 40 min of starting the clamp, plasma insulin and
glucose levels remained constant without further adjusting the pump
dial. At this steady state, insulin infusion should equal insulin clearance,
and the overall glucose utilization should reach a constant value. The
rate of glucose infusion at steady state normalized to the body weight
was used to determinate the glucose disposal rate (M) as an index of
insulin sensitivity.
Estimate of glucose utilization by individual tissues
As required by the theoretical model (21) a bolus of 80 mCi 2-deoxy-
d-[1-3H]glucose (Amersham, Aylesbury, UK) was injected iv into ani-
mals under steady state conditions. The same bolus was administered
to rats not infused with insulin to study basal glucose utilization. Blood
was sampled via arterial catheter for determination of insulin and glu-
cose concentrations and 2-deoxy-d-[1-3H]glucose radioactivity. Mea-
surements of plasma glucose and insulin levels before injecting the
radioactive bolus and at the end of the experiment (60 min) confirmed
that steady state conditions were maintained throughout the test. At the
end of the experiment, ratswere killed by cervical dislocation, andpieces
of brain, lungs, white adipose tissue (mixture of epididymal and ret-
roperitoneal), heart (ventricular portion), diaphragm, red and white
quadriceps, and soleus muscle were rapidly removed and frozen until
processing. Tissue samples were digested at 60 C for 45 min in plastic
tubes containing 1mNaOH and neutralized with 1mHCl. The 2-deoxy-
d-[1-3H]glucose-6-phosphate content was determined as described pre-
viously (22). This method is based on the fact that both 2-deoxyglucose
and 2-deoxyglucose-6-phosphate remain soluble in 6% HClO4 extracts,
whereas 2-deoxyglucose-6-phosphate precipitates in the Somogyi re-
agent [BaSO4/Zn(OH)2]. The rate of glucose utilization by each tissue
was calculated by dividing the disintegrations per min of 2-deoxy-d-
[1-3H]glucose-6-phosphate in the tissue by the calculated integral of the
ratio of arterial blood 2-deoxy-d-[1-3H]glucose to glucose concentration.
The data obtained are usually referred to as the glucosemetabolic index,
and they can be regarded as an index of glucose utilization at different
insulin levels (23). As the protein content of the tissues tested was not
different between old and young rats, the glucose utilization was ex-
pressed as milligrams per min/kg tissue.
Other analytical procedures
Plasma insulin was determined by RIA, using rat insulin as standard
(Incstar Corp., Stillwater, MN). Ketone bodies were determined accord-
ing to (24). Serum FFA were determined by an enzymatic kit (NEFA C,
Wako Chemicals, Neuss, Germany). Serum triglyceride were measured
with an enzymatic kit (ITC Diagnostics, Izasa, Spain).
Expression of the results
Results are expressed as the mean 6 sd. Statistical comparisons were
made using Student’s t test.
Results
Characteristics of the animals
The characteristics of the two groups of animals are shown
in Table 1. Young rats had plasma insulin and glucose con-
centrations identical to those observed in old animals, indi-
cating that they were mature with regard to the preservation
of glucose homeostasis. Changes in body composition were
reflected by increased body weight and fat tissue mass (18),
in agreement with data from others (7). Old animals showed
significantly elevated triglyceride levels, a characteristic also
observed in noninsulin-dependent diabetic patients and nor-
moglycemic/hyperinsulinemic individuals (25) as well as in
other rat strains in association with aging (26). In contrast,
although a relationship between fasting triglyceride and FFA
concentrations has been previously shown (25), FFA levels in
older rats were significantly lower. Ketone bodies were also
lower in old animals in concordance with the lower FFA
concentrations.
Euglycemic-hyperinsulinemic clamp
Table 2 shows the plasma insulin and glucose concentra-
tions reached at steady state, 45 min after starting the clamp.
In both groups, glucose concentrations were clamped at
identical levels, which were not different from those deter-
mined in animals not infused with insulin. Interestingly, the
plasma insulin concentrations at steady state were signifi-
cantly higher in old animals at both insulin infusion rates.
This has been previously observed in elderly humans at
insulin infusion rates leading to submaximal insulin concen-
trations during euglycemic clamp (3, 4), and the same can be
TABLE 1. Characteristics of the animals
3-Month-old
animals
24-Month-old
animals
BW (g) 424 6 24 727 6 76a
Fasting plasma glucose (mg/dl) 93.9 6 3.9 92.0 6 6.2
Fasting plasma insulin (mU/ml) 45 6 16 39 6 13
Fasting plasma ketone bodies
(mmol/ml)
0.94 6 0.48 0.29 6 0.04b
Fasting serum FFA (mEq/liter) 1.09 6 0.33 0.73 6 0.2c
Fasting serum triglyceride
(mg/dl)
82.7 6 31.0 196.7 6 63.3a
Data are the mean 6 SD of 7–15 separate determinations.
a P , 0.001 vs. 3-month-old animals.
b P , 0.01 vs. 3-month-old animals.
c P , 0.05 vs. 3-month-old animals.
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concluded from studies using agedWistar rats (7). An aging-
associated decrease in the MCR of insulin seems likely to be
the cause of these findings (27–30).
The rates of glucose infusion per kg BW required to main-
tain blood glucose concentrations during the clamp (M)were
markedly lower in the 24-month-old rats than in the young
controls (Table 2) at both insulin infusion rates, indicating the
insulin-resistant condition of the aged animals. At the high-
est plasma insulin levels reached during the clamp in young
and old rats,Nishimura et al. (7) reported that hepatic glucose
production was fully suppressed. Therefore, it can be as-
sumed that the rate of glucose infusion during the clamp is
equal to the rate of glucose utilization, and the differences
observed between young and old animals are probably due
to differences in glucose consumption by tissues and not to
higher hepatic glucose production in the older rats. How-
ever, at the lower insulin infusion rate used in these studies,
the insulin concentrations reached were reported to elicit a
lesser suppression of hepatic glucose production in old than
in adult animals (7), and it could consequently be argued that
differences in M in this case may be due to a higher hepatic
glucose production in older rats and not to the existence of
insulin resistance. However, the levels of glucose infused
into old rats at both insulin infusion rates are very similar,
suggesting that the production of glucose by the liver at the
lower insulin dose represents only a small part of the overall
glucose utilization that could not account by itself for the
decrease in M found in old rats.
Considering that fat tissue mass increases with aging,
many investigators have proposed to express glucose dis-
posal rates per kg lean body mass. In this work we have not
determined the fat-free mass of the rats, but from the simi-
larity in body weight between the animals in this study and
those used previously (7), we can tentatively assume that the
fat-free mass amounts to 62% and 55% of body weight in
young and old rats, respectively. Thiswould result in glucose
disposal rates of 28 and 20 mg/minzkg fat-free mass, for
young and old rats, respectively, at the highest insulin level,
indicating that old animals also show insulin resistancewhen
glucose disposal is calculated on a fat-free mass basis, in
agreement to similar findings in humans (27).
Glucose utilization in various tissues
The glucose metabolic index was estimated in control an-
imals (i.e. without insulin infusion) and in rats under eugly-
cemic-hyperinsulinemic conditions. Table 3 summarizes the
data obtained in eight tissues at three different insulin levels.
In white adipose tissue, basal glucose uptake was similar
in young and old animals. Maximal stimulation of glucose
utilization in young animals (3.75 fold) was reached at the
lower insulin dose used, with a slight decrease at higher
concentrations of the hormone, reflecting the elevated insulin
sensitivity of this tissue. In old rats, however, only a poor
insulin effect was observed at both insulin doses, suggesting
that adipose tissue becomes extremely insulin resistant with
aging.
In soleusmuscle anddiaphragm, basal glucose uptakewas
also similar in both groups of rats. However, insulin-induced
stimulation of glucose utilization was markedly lower in old
than in young animals at both insulin infusion rates, indi-
cating that these two tissues as well as white adipose con-
tribute actively to the insulin-resistant state of the old rats.
The increment in the glucose metabolic index at the lower
insulin infusion rate over that observed under basal condi-
tions can be compared with the maximal increment obtained
at saturating insulin concentrations to obtain a raw estima-
tion of the insulin sensitivity of the tissues. For the soleus
muscle and diaphragm, the stimulatory effect elicited by this
intermediate insulin concentration represents 75% and 69%,
respectively, of the maximal stimulation observed in young
animals, whereas in aged rats, this increment reaches only
33% and 26% of the maximal effect. These data clearly in-
dicate that the insulin sensitivity of both tissues is diminished
in old animals.
Uptake of glucose by the heart at saturating insulin con-
centrationswas similar in young and old animals, suggesting
that the maximal capacity of glucose utilization remains un-
altered with aging. However, at submaximal insulin con-
centrations, glucose uptake was significantly higher in
young rats, which indicates that at those intermediate insulin
levels the heart might also contribute to the decreased glu-
cose disposal observed in old animals. In contrast, under
basal conditions, glucose utilization was significantly ele-
vated in old rats. These data indicate that the insulin sensi-
tivity of the heart appears to decrease as a consequence of
aging. An approximate estimation from data in Table 3 sug-
gest that the insulin concentration necessary to induce the
half-maximal stimulation of glucose uptake in young ani-
mals should be lower than 100 mU/ml, whereas in old an-
imals it is around 200 mU/ml.
TABLE 2. Metabolic characteristics of the animals during euglycemic-hyperinsulinemic clamp
Age
(months)
Insulin infusion rate (U/hzkg)
0.3 0.6
Steady state plasma glucose (mg/dl) 3 89.8 6 21.0 96.8 6 15.6
24 86.7 6 1.4 92.3 6 11.4
Steady state plasma insulin (mU/ml) 3 207 6 18 508 6 32
24 384 6 114a 1037 6 158b
M (mg/minzkg) 3 14 6 0.9 17.4 6 2.9
24 9.6 6 0.8b 10.9 6 2.2b
Data were obtained from five or six different clamps performed with each group and represent the mean 6 SD.
a P , 0.01 vs. 3-month-old rats.
b P , 0.001 vs. 3-month-old rats.
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Concerning red and white quadriceps, the data in Table 3
indicate that there were no significant differences in glucose
uptake between young and old animals at the insulin con-
centrations tested, suggesting that these tissues are not in-
volved in the insulin resistance associated with aging. In
young animals, the increment in glucose uptake at interme-
diate insulin levels over that observed under basal conditions
represents 62% and 50% of the maximal increment for red
andwhite quadriceps, respectively, a percentage very similar
to the 58% and 62% of the maximal increment observed in
both tissues from aged animals. Thus, from these data it can
be postulated that the insulin sensitivity of both tissues re-
mains unchanged in old animals.
Finally, Table 3 shows that glucose utilization by brain and
lung was not stimulated by insulin in either group of rats.
Interestingly, whereas the glucose metabolic index of brain
is not influenced by the age of the animals, glucose utilization
by lung was decreased in aged rats at all three insulin con-
centrations tested.
Discussion
Whereas amarked impairment of peripheral insulin action
is well known to occur during maturation in rodents and
humans, aging of mature individuals has been associated
with a rather moderate decrease in peripheral insulin sen-
sitivity (3–8, 11–13). This last phenomenon was clearly
shown in humans, whereas in rats, different results were
obtained depending on the rat strain and the experimental
approach used. In this work we analyzed the in vivo glucose
disposal rate of mature young (3 months) and old (24
months)Wistar rats, using the euglycemic-hyperinsulinemic
clamp at two different insulin infusion rates. Our data clearly
demonstrate a significant decrease in overall glucose utili-
zation in the aged animals at both saturating and subsatu-
rating insulin concentrations, indicating that aging ofmature
Wistar rats is associatedwith a decrease in peripheral insulin
action. At the higher insulin infusion rate used in this work,
the steady state insulin concentrations reached during the
clamp in both young and old animals have been previously
shown to induce a maximal glucose disposal rate in the
Wistar rat (7). Consequently, we can tentatively speculate
that in aged rats, the maximal response to the hormone is
decreased. These results confirm previous observations by
Nishimura et al. (7), although in our study the differences in
glucose disposal rate reach statistical significance,whereas in
their study (7) this was the case only at lower insulin con-
centrations. Additionally, these data are consistent with the
findings in elderly humans (3, 4, 27) who lack genetic com-
mitments to develop noninsulin-dependent diabetes.
Some researchers have claimed that peripheral insulin re-
sistance in aged rats is simply a consequence of increases in
body weight and fat mass or is due to physical inactivity.
Although it is well documented that these factors affect in-
sulin sensitivity, there is considerable experimental evidence
demonstrating that insulin resistance in aged animals and
humans also occurs in the absence of increased adiposity and
body weight (17, 27) or after training protocols that are usu-
ally effective in improving insulin sensitivity (10, 13).
In the present work we also explored the effect of aging on
the glucose metabolic index of several insulin target tissues
at different plasma insulin concentrations. As the 24-month-
old rats are normoinsulinemic and normoglycemic, these
TABLE 3. Glucose metabolic index of different tissues of young and old rats under basal conditions and at two different insulin
concentrations during euglycemic-hyperinsulinemic clamp
Tissue Age (months)
Insulin infusion rate (U/hzkg)
0 0.3 0.6
White adipose tissue 3 0.8 6 0.4 3.0 6 0.7a (3.75) 2.3 6 0.6a (2.87)
24 1.1 6 0.4 1.7 6 0.9b (1.54) 1.6 6 0.6b (1.45)
Soleus 3 2.7 6 0.2 11.4 6 4.3c (4.22) 14.2 6 2.8a (5.25)
24 2.9 6 0.8 4.5 6 1.6b (1.55) 7.7 6 3.5b,d (2.65)
Diaphragm 3 10.8 6 4.8 59.9 6 19.1a (5.54) 81.5 6 10.9a (7.54)
24 18.9 6 7.9 24.9 6 8.9b (1.31) 40.7 6 11.1d,e (2.15)
Heart 3 5.5 6 2.2 86.2 6 20.9a (15.67) 87.9 6 9.4a (15.98)
24 22.2 6 15.3f 65.1 6 11.2c,f (2.93) 78.5 6 14.2c (3.53)
Red quadriceps 3 5.5 6 0.9 21.5 6 5.6a (3.9) 30.5 6 10.2a (5.54)
24 6.8 6 1.7 17.6 6 5.0c (2.6) 26.2 6 11.5c (3.85)
White quadriceps 3 3.2 6 0.7 12.8 6 4.1c (4.0) 22.5 6 5.2a (7.03)
24 4.1 6 0.5 11.7 6 4.9d (2.85) 16.0 6 4.7c (3.9)
Brain 3 23.9 6 4.1 20.5 6 8.6 21.3 6 3.1
24 19.5 6 2.2 16.7 6 2.3 20.8 6 1.9
Lung 3 12.4 6 1.7 10.9 6 6.0 12.7 6 0.9
24 7.1 6 1.0b 8.8 6 1.1 7.8 6 1.2e
Data are expressed as milligrams per min/kg and are the mean 6 SD of four to eight independent determinations in each case. Values in
parentheses indicate the fold stimulation of glucose utilization elicited by insulin infusion with respect to that observed under basal conditions.
a P , 0.001 vs. basal.
b P , 0.01 vs. young.
c P , 0.01 vs. basal.
d P , 0.05 vs. basal.
e P , 0.001 vs. young.
f P , 0.05 vs. young.
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studies allowed us to determine which tissues contribute
primarily to the development of insulin resistance. From our
data it becomes evident that white adipose tissue is ex-
tremely insulin resistant in the old rats. These results are
consistent with our previous observations in isolated adipo-
cytes (18, 31) that showed a decreased insulin stimulation of
several metabolic functions as well as a reduced insulin re-
ceptor kinase activity and with observations by others in
human adipocytes (27). Even though adipose tissue uses only
aminor part of the glucose available, it should be pointed out
that a greater proportion of fat mass is present in the older
animals, making its contribution to the overall insulin resis-
tance more relevant. Reaven (25) suggested that the insulin
resistance of adipose tissue in type 2 diabetics could be rel-
evant not quantitatively, in terms of glucose utilization, but,
rather, qualitatively. Thus, the lack of an antilipolytic effect
of insulin or a decreased stimulation of adipocyte-associated
lipoprotein lipase could lead to increases in plasma FFA and
triglyceride levels that might, in turn, induce a decrease in
glucose utilization by other tissues. In fact, fasting serum
triglyceride levels were elevated in the old rats used in this
work, in agreement with previous reports using Fischer-344
rats (26). In contrast, the serum FFA concentration appears
to be decreased in old animals. More experimental work is
required to elucidate whether this is due to decreased adi-
pocyte fatty acid production or increased liver fatty acid
utilization for triglyceride synthesis. Our results here indi-
cate that the insulin insensitivity of adipose tissue could be
a primary defect associated with aging, and it is of great
interest to establish at which age this resistance is detectable.
We also found that insulin-stimulated glucose uptake by
the diaphragm is markedly reduced in old rats at saturating
and subsaturating insulin concentrations, whereas basal uti-
lization remains unaltered. Furthermore, from our data it can
be postulated that the insulin sensitivity of the diaphragm is
decreased in the aged rat. A previous report using isolated
diaphragm from Wistar rats claimed that insulin resistance
occurs during maturation, but no further decrease in insulin
action was observed with aging (32). As our data were ob-
tained in vivo, they cannot be directly compared with the
former. It is possible that in vitro studies with isolated dia-
phragm do not fully reproduce the conditions existing in
vivo, resulting in a loss of its insulin resistance.
In contrast to the former tissues, the glucose metabolic
index of heart in the presence of saturating insulin reaches
similar levels in young and old animals, indicating that the
metabolic capacity of heart is not influenced by aging. How-
ever, at subsaturating insulin concentrations, glucose utili-
zation is lower in the old animals, whereas in the presence
of physiological plasma insulin concentrations, glucose uti-
lization is higher in old rats. Taken together, these data sug-
gest that in the hearts of old animals the insulin sensitivity
is decreased without changes in the maximal response to the
hormone.
Finally, concerning skeletal muscles, it appears evident
from our data that insulin resistance develops mainly in
certain muscle types. Thus, whereas decreases in old rats in
glucose utilization by the red and white portions of the
quadriceps at both insulin infusion rates are rather low, the
stimulation by insulin of glucose utilization in the soleus is
greatly reduced in aged animals. Furthermore, the insulin
sensitivity of red and white quadriceps is unaltered with
aging, in contrast to the acute decrease observed in the soleus
muscle of old rats. These three muscle tissues differ in fiber
type composition, with the soleus being mainly constituted
by type 1 fibers, and the white and red quadriceps by type
2b and 2a fibers, respectively (12). The type 1 fibers of the
soleus are oxidative and can use fatty acids as fuel, whereas
type 2b fibers are extremely glycolytic and cannot oxidize it
(33). Thus, it can be speculated that the insulin-resistant
adipose tissue of the older rats incorporates a lesser amount
of fatty acids from lipoprotein triglyceride that remain avail-
able as an alternative fuel to glucose for oxidative muscles
such as soleus or even heart. The greater availability of fatty
acids, however, would not influence glucose utilization by
glycolytic muscles such as quadriceps.
Taking into account that slow twitch fibers represent only
about 10% of the rat muscle mass, it appears difficult to
reconcile the observed decrement in overall glucose disposal
with the development of insulin resistance in the oxidative
muscles and diaphragm. In this regard there are several
considerations. Firstly, the lower glucose utilization by lungs
in old animals reported here could partially contribute to the
decreased glucose disposal. On the other hand, it has been
proposed that aging is associated with a preferential loss of
fast twitch fibers and a progressive increase in the proportion
of aerobic type 1 fibers that would be insulin resistant (33).
Finally, it cannot be ruled out that other tissues are contrib-
uting to the decreased glucose disposal or even that, as ex-
periments were performed with anesthetized rats, the con-
tribution of diaphragm to the total glucose utilization might
be overestimated, resulting in a higher decrement in glucose
disposal.
The development of tissue-specific insulin resistance
could also be due to regional changes in blood flow. How-
ever, although insulin stimulation of peripheral blood flow
has been shown to be impaired in several cases of insulin
resistance (34–36), considerable experimental evidence has
dissociated the increase in glucose utilization from the in-
crement in regional blood flow (37). Thus, it seems unlikely
that specific changes in blood flow are the ultimate cause of
the tissue-specific decrease in glucose uptake.
To summarize, our data demonstrate that normoglycemic
and normoinsulinemic 24-month-old Wistar rats show in-
sulin resistance in vivo, as manifested by the decreased glu-
cose disposal rates under hyperinsulinemic conditions. Some
insulin target tissues, such as diaphragm, soleus muscle,
heart, and white adipose tissue, play a primary role in de-
velopment of the insulin-resistant condition associated with
aging, whereas the other mainly glycolytic muscles remain
sensitive to the hormone.
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